Cargando…
Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models
Intracerebral hemorrhage is a fatal subtype of stroke, with crucial impact on public health. Surgical removal of the hematoma as an early-stage treatment for ICH can’t improve long-term prognosis remarkably. Liangxue tongyu prescription (LP), a Traditional Chinese Medicine (TCM) formula, includes ei...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232344/ https://www.ncbi.nlm.nih.gov/pubmed/30459599 http://dx.doi.org/10.3389/fphar.2018.01169 |
_version_ | 1783370386588565504 |
---|---|
author | Li, Xun Huang, Xi Tang, Yuanlin Zhao, Fangli Cao, Yanmei Yin, Lian Li, Guochun |
author_facet | Li, Xun Huang, Xi Tang, Yuanlin Zhao, Fangli Cao, Yanmei Yin, Lian Li, Guochun |
author_sort | Li, Xun |
collection | PubMed |
description | Intracerebral hemorrhage is a fatal subtype of stroke, with crucial impact on public health. Surgical removal of the hematoma as an early-stage treatment for ICH can’t improve long-term prognosis remarkably. Liangxue tongyu prescription (LP), a Traditional Chinese Medicine (TCM) formula, includes eight ingredients and has been used to treat ICH in the clinical. In the study, we elucidated the pharmacological efficacy and therapeutic efficacy of LP to dissect the mechanism of LP against ICH via network analysis and experimental validation. First, we discovered 34 potential compounds and 146 corresponding targets in LP based on network prediction. 24 signal pathway were obtained by the Clue Go assay based on potential compounds in LP against ICH. Second, we found that LP can not only decreased the level of high sensitive C reactive protein (HS-CRP), tumor necrosis factor-α (TNF-α), NF-kβ, D-dimmer (D2D), estradiol (E2), S-100B, neuron specific enolase (NSE), and interleukin 1 (IL-1) in plasma on spontaneously hypertensive rats (SHRs), but also promoted cell proliferation and inhibited cell apoptosis on the glutamate-induced PC12 cell. The compounds including Taurine, Paeonol, and Ginsenoside Rb1 in LP can activate PI3K/AKT pathway. Third, from the three-factor two-level factorial design, compound combinations in LP, such as Taurine and Paeonol, Taurine and Geniposide, Ginsenoside Rg1, and Ginsenoside Rb1, had first-level interactions on cell proliferation. Compound combinations including Taurine and Paeonol, Ginsenoside Rg1 and Ginsenoside Rb1 had as significant increase in efficiency on inhibiting the apoptosis of PC12 cells at the low concentration and up-regulating of PI3K and AKT. Overall, our results suggested that LP had integrated therapeutic effect on ICH due to activities of anti-inflammatory, anti-coagulation, blood vessel protection, and protection neuron from excitotoxicity based on the way of “multi-component, multi-target, multi-pathway,” and compound combination in LP can offer protection neuron from excitotoxicity at the low concentration by activation of the PI3K/Akt signal pathway. |
format | Online Article Text |
id | pubmed-6232344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62323442018-11-20 Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models Li, Xun Huang, Xi Tang, Yuanlin Zhao, Fangli Cao, Yanmei Yin, Lian Li, Guochun Front Pharmacol Pharmacology Intracerebral hemorrhage is a fatal subtype of stroke, with crucial impact on public health. Surgical removal of the hematoma as an early-stage treatment for ICH can’t improve long-term prognosis remarkably. Liangxue tongyu prescription (LP), a Traditional Chinese Medicine (TCM) formula, includes eight ingredients and has been used to treat ICH in the clinical. In the study, we elucidated the pharmacological efficacy and therapeutic efficacy of LP to dissect the mechanism of LP against ICH via network analysis and experimental validation. First, we discovered 34 potential compounds and 146 corresponding targets in LP based on network prediction. 24 signal pathway were obtained by the Clue Go assay based on potential compounds in LP against ICH. Second, we found that LP can not only decreased the level of high sensitive C reactive protein (HS-CRP), tumor necrosis factor-α (TNF-α), NF-kβ, D-dimmer (D2D), estradiol (E2), S-100B, neuron specific enolase (NSE), and interleukin 1 (IL-1) in plasma on spontaneously hypertensive rats (SHRs), but also promoted cell proliferation and inhibited cell apoptosis on the glutamate-induced PC12 cell. The compounds including Taurine, Paeonol, and Ginsenoside Rb1 in LP can activate PI3K/AKT pathway. Third, from the three-factor two-level factorial design, compound combinations in LP, such as Taurine and Paeonol, Taurine and Geniposide, Ginsenoside Rg1, and Ginsenoside Rb1, had first-level interactions on cell proliferation. Compound combinations including Taurine and Paeonol, Ginsenoside Rg1 and Ginsenoside Rb1 had as significant increase in efficiency on inhibiting the apoptosis of PC12 cells at the low concentration and up-regulating of PI3K and AKT. Overall, our results suggested that LP had integrated therapeutic effect on ICH due to activities of anti-inflammatory, anti-coagulation, blood vessel protection, and protection neuron from excitotoxicity based on the way of “multi-component, multi-target, multi-pathway,” and compound combination in LP can offer protection neuron from excitotoxicity at the low concentration by activation of the PI3K/Akt signal pathway. Frontiers Media S.A. 2018-11-06 /pmc/articles/PMC6232344/ /pubmed/30459599 http://dx.doi.org/10.3389/fphar.2018.01169 Text en Copyright © 2018 Li, Huang, Tang, Zhao, Cao, Yin and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Xun Huang, Xi Tang, Yuanlin Zhao, Fangli Cao, Yanmei Yin, Lian Li, Guochun Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title | Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title_full | Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title_fullStr | Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title_full_unstemmed | Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title_short | Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models |
title_sort | assessing the pharmacological and therapeutic efficacy of traditional chinese medicine liangxue tongyu prescription for intracerebral hemorrhagic stroke in neurological disease models |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232344/ https://www.ncbi.nlm.nih.gov/pubmed/30459599 http://dx.doi.org/10.3389/fphar.2018.01169 |
work_keys_str_mv | AT lixun assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT huangxi assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT tangyuanlin assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT zhaofangli assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT caoyanmei assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT yinlian assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels AT liguochun assessingthepharmacologicalandtherapeuticefficacyoftraditionalchinesemedicineliangxuetongyuprescriptionforintracerebralhemorrhagicstrokeinneurologicaldiseasemodels |